Stryker acquired privately-held OrthoSensor, a Florida-based leader in sensor technology for total joint replacement. OrthoSensor’s intelligent devices and data services help care providers develop data-based treatments.
The acquisition gives Stryker increased digital capabilities across the continuum of care. The intraoperative VERASENSE™ sensor creates a unique knee balancing solution. Used with Stryker’s Triathlon Knee system since 2011, VERASENSE will enhance Mako SmartRobotics™. Meanwhile, the MotionSense™ remote patient monitoring wearable and OrthologIQ® cloud-based data platform complement Stryker’s existing data analytics.
Despite facing what promises to be a challenging integration effort with Wright Medical, Stryker remains committed to seeking attractive tuck-in opportunities after a mid-2020 period that company CEO Kevin Lobo described as “pencils down” for acquisitions.
This purchase strengthens Stryker’s already significant competitive advantage in knee replacement. The company’s knee sales returned to growth in 3Q20 (+2.7%), recovering from the pandemic low point more quickly than its peers. Stryker’s Mako robot also surpassed the 1,000-install mark in 3Q, and company leadership expects a “record-setting” 4Q for the system.
The acquisition of OrthoSensor could also impact Stryker’s competitors. Exactech and OrthoSensor exclusively collaborated in April 2020 on the first reverse total shoulder replacement using VERASENSE. In that same month, OrthoSensor gained FDA 510(k) alignment clearance for the use of VERASENSE with Zimmer Biomet’s Persona Knee system.